Compare magnetic stimulation and EEG-based feedback by mechanism, session experience, clinical purpose and evidence.
EXOMIND and neurofeedback are different technologies. EXOMIND is a non-invasive magnetic brain-stimulation system in the broader rTMS family. Neurofeedback records brain activity and provides real-time feedback so the client can practise self-regulation. One delivers magnetic pulses; the other is a feedback-based learning process.
| EXOMIND | Neurofeedback | |
|---|---|---|
| Mechanism | Magnetic stimulation | EEG measurement plus feedback |
| Client role | Sits while stimulation is delivered | Participates in feedback-based training |
| Electrical recording | Not the treatment mechanism | Scalp EEG guides feedback |
| Planning | Requires clinical and safety screening | Requires goals, protocol selection and tracking |
How does EXOMIND work?
A treatment coil generates changing magnetic fields that induce small electrical currents in targeted cortical tissue. The client remains awake, and no surgery or implanted device is involved. Treatment parameters and suitability should be determined by an appropriately trained provider after screening for contraindications and relevant medical history.
Research on repetitive transcranial magnetic stimulation is strongest for specific clinical indications and protocols. A 2023 network meta-analysis supports the efficacy and acceptability of several rTMS approaches for major depressive episodes. That evidence should not be generalized automatically to every wellness or performance claim, or to every device and protocol.
How does neurofeedback work?
Neurofeedback uses scalp sensors to record selected EEG features. Software turns those signals into immediate visual or audio feedback, allowing the client to practise changing a targeted pattern over multiple sessions. Standard neurofeedback sensors monitor activity; they do not stimulate the brain.
Evidence varies by condition, outcome and protocol. For ADHD, a 2025 systematic review found no meaningful group-level improvement in total symptoms when rated using probably blinded outcomes, although some protocol-specific and secondary outcomes differed. Claims should therefore stay tied to the evidence and to measured individual response.
Which option is better?
Neither is universally better. The meaningful question is whether either option fits the clinical goal, safety profile, available evidence and alternatives. A person seeking evidence-based treatment for depression presents a different question from someone exploring attention training or cognitive performance.
- Start with the target: define the symptom or functional change you want to address.
- Clarify the diagnosis: assessment may be needed before technology is selected.
- Review safety and alternatives: include medical and psychological options.
- Choose outcome measures: decide in advance how progress will be judged.
- Reassess: continue, adjust or stop based on benefit, burden and clinical judgment.
Calgary Mind & Wellness Clinic places technology within a broader care plan. Explore EXOMIND, neurofeedback, depression treatment and our clinician-guided brain optimization in Calgary.
Frequently asked questions
Is EXOMIND a type of neurofeedback?
No. EXOMIND delivers magnetic stimulation. Neurofeedback records EEG activity and provides feedback for training.
Does neurofeedback stimulate the brain?
Standard EEG neurofeedback records brain activity through scalp sensors and provides visual or auditory feedback; it does not deliver magnetic pulses.
Can either treatment replace assessment?
No. Technology should not substitute for an appropriate clinical evaluation, especially when diagnosis, safety or treatment selection is uncertain.
Are results guaranteed?
No. Response varies by person, condition and protocol. A responsible plan uses realistic goals and tracks outcomes.
Clinically reviewed
Dr. Courtney Dookie, Registered Psychologist
Declared competence in Clinical Psychology and Neuropsychology.
References
- Repetitive transcranial magnetic stimulation for major depressive episodes: network meta-analysis
- Neurofeedback for ADHD: systematic review and meta-analysis
Unsure which next step fits?
A clinician can help clarify the target, evidence, safety considerations and how progress would be measured.